AMYPAD

Amyloid imaging to prevent Alzheimer’s disease.

Title	AMYPAD
Description	Amyloid imaging to prevent Alzheimer’s disease AMYPAD aims to determine the value of ß-amyloid imaging as a diagnostic & therapeutic marker for Alzheimer’s disease.
Status	Active
PI	Prof Craig Ritchie
Edinburgh Imaging Collaborator	Dr Laura Doull
Disease	Dementia
Facility / resource	EIF QMRI
Project type	Multi-centre collaboration
Funding	European Federation of Pharmaceutical Industries and Associations (EFPIA) European Union’s Horizon2020 Innovative Medicines Initiative 2 Joint Undertaking

This article was published on 15 Jul, 2019